“Therapeutic Effects of Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors in Dyslipidemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”. Althea Medical Journal 12, no. 3 (September 30, 2025): 161–171. Accessed July 18, 2026. https://journal.fk.unpad.ac.id/index.php/amj/article/view/4209.